KAVI Institute of Clinical Research (KAVI-ICR)
Research - Nairobi, Nairobi County, Kenya
KAVI Institute of Clinical Research (KAVI-ICR) Employees
KAVI Institute of Clinical Research (KAVI-ICR) Senior Management
KAVI Institute of Clinical Research (KAVI-ICR) Details
Kenya AIDS Vaccine Initiative (KAVI) was established in 1998 as a research unit within theDepartment of Medical Microbiology, College of Health Sciences, University of Nairobi, withan initial mission to conduct basic research in epidemiology of HIV and to carryout HIV/AIDsvaccine trials. By 2013, KAVI as a research unit had successfully undertaken eight HIV vaccine trials,two drug trials, thirteen epidemiological and basic research projects in addition to pioneeringthe development of mucosal sampling and standardization of mucosal immune assays. KAVIhas also greatly assisted in the development of human capacity within the East African regionby training various Institutional Ethics boards and clinical research personnel on researchethics, (GCP) and (GCLP). KAVIhas also been involved in the strengthening of Laboratory management systems of varioushealth institutions to prepare the institutions for accreditation.Philosophical FrameworkThe process of "Strategic Planning" involves the collective effort to answer a setof fundamental questions; where are we now, where do we want to be and howdo we get there.VisionAn institute of excellence in health research, innovation and knowledgetranslation.MissionTo discover, apply and disseminate knowledge through creative and innovativehealth research.Core Values1. Freedom of thought and expression: We shall promote and uphold freedom of thought and expression in academic inquiry and knowledge translation.2. Creativity and Innovativeness shall be the hallmark of our research projects/programs.3. Professionalism: We shall maintain professional etiquette and honesty. We shall conduct research according to established national and internationalresearch standards.4. Team spirit and team work: We shall nurture a research culture that is participatory and non-discriminatory.5. Transparency and Accountability: We shall embrace and practice good corporate governance.
